Stockreport

Mesoblast cell therapy shows significant benefit in COVID-19 patients [Seeking Alpha]

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com
PDF Thinly traded Mesoblast Limited (NASDAQ:MESO51%announcementBy comparison, 9% (n=38/445) of ventilator-dependent COVID-19 patients at a major New York City hospital who r [Read more]